Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Drug: Sonrotoclax
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT06859008·Phase 1·Recruiting·Listed Mar 2025